In this randomized control trial of neuromyelitis optica spectrum disorder (NMOSD) patients with aquaporin-4 antibodies (AQP4-IgG), those randomized to receive the eculizumab complement inhibitor experienced a lower relapse rate over 24 months than placeb
by 2minmed 5 years ago | via Instagram
. . . . . . . #photography #photograph #photographer #photooftheday #beautiful #art #travel #nature #picoftheday #travelphotography #love #happy #instagood
by gwenlee0201 7 years ago | via Instagram
A day of doing nothing is quite nice too . . . . . . . #photography #photograph #photographer #photooftheday #beautiful #art #travel #nature #picoftheday #travelphotography #love #happy #instagood #foodie #foodporn #VANFOODIE
by gwenlee0201 7 years ago | via Instagram
Last meal in Taiwan . . . . . . . #photography #photograph #photographer #photooftheday #beautiful #art #travel #nature #picoftheday #travelphotography #love #happy #instagood #food #foodie #foodporn
by gwenlee0201 7 years ago | via Instagram

Trusted by more than 200,000 websites since 2011